WinstonWınston
SBC Medical Group Holdings Incorporated logo

SBC Medical Group Holdings Incorporated

SBCWW
65
Consulting Services · Industrials
Price
$0.26
+0.02 (+8.33%)
Market Cap
$26.7M
Exchange
NASDAQ Global Market
Winston Score
65
Winston is curious
A decent business — some strong pillars, some weaker.
Data as of Jul 25, 2026 · filings through Mar 31, 2026

Share count rising — dilution

+583.6% over 3y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 15.1M (2022) → 103.0M (2025)

SBC Medical Group Holdings is a Japanese company that provides management and consulting services to cosmetic medicine clinics. Instead of running clinics directly, it supports a network of franchised aesthetic clinics across Japan — helping them with staffing, purchasing, marketing, and operations. The cosmetic medicine industry in Japan is large and growing, driven by rising consumer interest in non-surgical beauty treatments.

The company earns money by charging franchise fees and providing services to the clinics in its network, rather than collecting patient fees directly. This asset-light model helps explain its strong gross margin of around 71%. SBC operates primarily in Japan, though it has begun exploring expansion into other Asian markets. Its main competitive advantage is its established franchise network and brand recognition in Japan's cosmetic clinic space. The key growth driver is expanding its clinic count domestically and internationally, while the main risk is regulatory changes around cosmetic medical procedures in Japan.

Winston Score History

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
70.5%
Premium pricing power — 70.5% gross margin
Operating Margin
41.2%
Excellent — 41.2% operating margin
ROCE
5.9%
Weak — 5.9% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-14.4%
Shrinking sales (-14.4% YoY)
EPS YoY
-47.0%
Earnings shrinking (-47.0% YoY)

Earnings per share down more than 10%. Either a bad year, or a real decline.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
113%
Turns 113% of profit into real cash
FCF Margin
26.0%
Converts sales into free cash efficiently (26.0%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.18
Conservative — low debt load (0.18)
Interest Cover
226.63x
Comfortably covers interest (226.6x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
0.7x
Attractive valuation — P/E 0.7

P/E under 10. The price tag is small relative to last year's profit.

P/E vs Forward
+0.1
GROWING
Earnings roughly flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial